Aerie Pharmaceuticals, Inc. - Common Stock (NQ:AERI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aerie Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Retina Innovation Showcase

October 07, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Announces Presentation at the 39th Annual Scientific Meeting of the American Society of Retina Specialists

October 06, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals to Participate in the Cantor Global Healthcare Conference

September 27, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

Aerie Pharmaceuticals, Inc. Announces the Appointment of Interim Executive Chair and Departure of Chairman and CEO

September 21, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition

September 20, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

56 Biggest Movers From Yesterday ↗

September 17, 2021

Check out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 70 Points; Aerie Pharmaceuticals Shares Plunge ↗

September 16, 2021

Toward the end of trading Thursday, the Dow traded down 0.20% to 34,745 while the NASDAQ fell 0.03% to 15,157.61. The S&P also fell, dropping 0.21% to 4,471.34. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 16, 2021

Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump ↗

September 16, 2021

Midway through trading Thursday, the Dow traded down 0.74% to 34,557.75 while the NASDAQ fell 0.67% to 15,060.25. The S&P also fell, dropping 0.79% to 4,445.34. The U.S. has...

Via Benzinga

Topics Stocks

38 Stocks Moving In Thursday's Mid-Day Session ↗

September 16, 2021

Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS...

Via Benzinga

Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet ↗

September 16, 2021

A study in eye-disease treatment missed its mark, leading this biotech stock to dive.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Down; US Retail Sales Unexpectedly Increase in August ↗

September 16, 2021

Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also fell, dropping 0.62% to 4,453.04. The U.S...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 16, 2021

Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

September 16, 2021

Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as the most-discussed stock on Reddit’s r/...

Via Benzinga

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial ↗

September 16, 2021

Aerie Pharmaceuticals Inc (NASDAQ: AERI) announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 15, 2021

Gainers Larimar Therapeutics (NASDAQ:

Via Benzinga

Aerie Pharmaceuticals Announces Novel Dry Eye Product Candidate AR-15512 (TRPM8 Agonist) Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms and Signs in Successful Phase 2b Clinical Study for the Treatment of Dry Eye Disease

September 15, 2021

From Aerie Pharmaceuticals

Via Business Wire

Aerie Pharmaceuticals Announces Appointment of Carolyn McAuliffe, Senior Director, Communications

September 13, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences

September 07, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Announces Appointment of Michael Bradley, Senior Director, Manufacturing

September 07, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Looking into Aerie Pharmaceuticals's Return on Capital Employed ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, Aerie Pharmaceuticals (NASDAQ:AERI) posted sales of $27.18 million. Earnings were up 7.94%, but Aerie Pharmaceuticals...

Via Benzinga

Aerie Pharmaceuticals to Participate in the H.C. Wainwright Ophthalmology Conference

August 12, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 10, 2021

Gainers CohBar (NASDAQ:CWBR) shares incr...

Via Benzinga

Aerie Pharmaceuticals, inc (AERI) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

AERI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Aerie Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

August 04, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021

July 28, 2021

From Aerie Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.